Sarah Innamorati

Sarah Innamorati is a skilled professional in analytical development and quality control with extensive experience in the bio-pharmaceutical industry. Currently serving as Senior Manager at Dyne Therapeutics since September 2022, Sarah oversees analytical vendors and is responsible for comprehensive tracking and analysis of antibody-drug conjugate data. Prior to this position, Sarah held roles at Pfizer, Dana-Farber Cancer Institute, and Boston Heart Diagnostics, where responsibilities included assay validation, QC testing, and medical technology functions, alongside substantial contributions to compliance and training initiatives. Sarah holds a Master of Science in Pharmacology from Michigan State University and a Bachelor of Science in Forensic Biology from Western New England University.